Publication | Closed Access

Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy

UrologyPoor OutcomesGenitourinary CancerMedicineExpression Deemed IneligibleCancer ManagementCancer TreatmentProstatic DiseaseOncologyRadiation Oncology